美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

iShares MSCI Argentina and Global Exposure ETF

26.38

0.0000

成交量：- -

成交额：- -

市值：527.60万

市盈率：- -

高：26.38

开：26.38

低：26.38

收：26.38

52周最高：31.89

52周最低：19.95

股本：20.00万

流通股本：20.00万

量比：- -

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

信达生物与圣因生物共同宣布IBI3016（AGT siRNA）I期临床研究结果于2025年AHA大会现场报告

信立泰(002294.SZ)获得AGT-siRNA药物GW906独家许可权益

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/AGT"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"AGT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGT\",,,,,undefined,":{"symbol":"AGT","market":"US","secType":"STK","nameCN":"iShares MSCI Argentina and Global Exposure ETF","latestPrice":26.38,"timestamp":1662148800000,"preClose":26.38,"halted":0,"volume":0,"delay":0,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"休市中","change":0,"latestTime":"09-02 16:00:00 EDT","open":26.38,"high":26.38,"low":26.38,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":26.38,"sharesOutstanding":200000,"nav":26.4147,"aum":5283411.86,"bidAskSpread":0.002165,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGT\",,,,,undefined,":{"symbol":"AGT","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"shares":200000,"dividePrice":0,"high":26.38,"amplitude":0,"preClose":26.38,"low":26.38,"week52Low":19.95,"pbRate":"--","week52High":31.89,"institutionHeld":0,"latestPrice":26.38,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":26.38,"prevYearClose":26.8655},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-23","symbol":"AGT","reason":null,"defaultRemindTime":1661261400000,"announcedDate":"2022-06-27","type":"delisting","dateTimestamp":1661227200000},{"market":"US","date":"2022-06-09","symbol":"AGT","amount":0.414912,"defaultRemindTime":1654781400000,"name":"iShares MSCI Argentina and Global Exposure ETF","recordDate":"2022-06-15","payableDate":"2022-06-10","currency":"USD","type":"dividend","dateTimestamp":1654747200000},{"market":"US","date":"2021-12-13","symbol":"AGT","amount":0.233806,"defaultRemindTime":1639405800000,"name":"iShares MSCI Argentina and Global Exposure ETF","recordDate":"2021-12-17","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2021-06-10","symbol":"AGT","amount":0.044975,"defaultRemindTime":1623331800000,"name":"iShares MSCI Argentina and Global Exposure ETF","recordDate":"2021-06-16","payableDate":"2021-06-11","currency":"USD","type":"dividend","dateTimestamp":1623297600000},{"market":"US","date":"2020-12-14","symbol":"AGT","amount":0.171053,"name":"iShares MSCI Argentina and Global Exposure ETF","recordDate":"2020-12-18","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGT\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-25","value":0.203547,"currency":"USD"},{"executeDate":"2018-12-18","recordDate":"2018-12-19","paymentDate":"2018-12-24","value":0.023372,"currency":"USD"},{"executeDate":"2019-06-17","recordDate":"2019-06-18","paymentDate":"2019-06-21","value":0.223864,"currency":"USD"},{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.081776,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.063899,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGT\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582811076","title":"信达生物与圣因生物共同宣布IBI3016（AGT siRNA）I期临床研究结果于2025年AHA大会现场报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2582811076","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582811076?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 08:00","pubTimestamp":1762732800,"startTime":"0","endTime":"0","summary":"在北京大学第三医院研究中心、信达生物和圣因生物三方的通力协作与专业投入下，IBI3016 I期得到了良好的阶段性成果并在国际大会中汇报。IBI3016基于圣因生物专有小核酸药物开发平台具有自主知识产权的GalNAc肝靶向递送技术开发，通过RNAi机制抑制AGT的合成。临床前试验数据显示，IBI3016可抑制AGT在肝脏中的合成，从而可能导致AGT蛋白的持久减少，进一步导致Ang II 的减少，最终起到舒张血管、降低血压的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4818720_ZH18720_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["AGT","BK1161","LU2328871848.SGD","LU2097828805.USD","LU2097828557.USD","BK1583","01801","HK0000165453.HKD","LU2488822045.USD","LU2097828714.EUR","BK1589","LU0455707207.USD","LU2097828474.EUR","LU2097828631.EUR","IVBIY","LU2242644610.SGD","LU0502904849.HKD","LU1969619763.USD","BK4139"],"gpt_icon":0},{"id":"2538103084","title":"信立泰(002294.SZ)获得AGT-siRNA药物GW906独家许可权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2538103084","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538103084?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 19:53","pubTimestamp":1748260393,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信立泰 发布公告，为进一步丰富公司在慢病领域的创新产品管线，公司拟与成都国为生物医药有限公司签订协议，获得国为生物在研AGT-siRNA药物GW906的原料药及制剂相关知识产权、技术信息于中国市场的独家许可权益，包括但不限于产品的研发、注册、生产及商业化等。公司将根据交易进度和研发进展情况以自筹资金付款。其中，首付款及研发里程碑款总金额最高不超过1.8亿元。本次交易后，公司将获得在研AGT-siRNA药物GW906中国市场的独家权益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1297710.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"信立泰(002294.SZ)获得AGT-siRNA药物GW906独家许可权益","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","AGT","BK0187","BK0028","BK0183","BK0239","BK0196","002294"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AGT\",params:#limit:6,delay:false,,,undefined,":[]}}